These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34009465)

  • 1. Hyaluronan, a double-edged sword in kidney diseases.
    Kaul A; Singampalli KL; Parikh UM; Yu L; Keswani SG; Wang X
    Pediatr Nephrol; 2022 Apr; 37(4):735-744. PubMed ID: 34009465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis.
    Lewis A; Steadman R; Manley P; Craig K; de la Motte C; Hascall V; Phillips AO
    Histol Histopathol; 2008 Jun; 23(6):731-9. PubMed ID: 18366011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of hyaluronan and its binding receptors in an experimental model of chronic cyclosporine nephropathy.
    Han DH; Song HK; Lee SY; Song JH; Piao SG; Yoon HE; Ghee JY; Yoon HJ; Kim J; Yang CW
    Nephrology (Carlton); 2010 Mar; 15(2):216-24. PubMed ID: 20470282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan.
    Stridh S; Palm F; Takahashi T; Ikegami-Kawai M; Hansell P
    Ups J Med Sci; 2015; 120(4):233-40. PubMed ID: 26175092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of common and specific fibrosis-related genes in three common chronic kidney diseases.
    Fu Z; Geng X; Liu C; Shen W; Dong Z; Sun G; Cai G; Chen X; Hong Q
    Ren Fail; 2024 Dec; 46(1):2295431. PubMed ID: 38174742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemia-induced renal expression of hyaluronan and CD44 in diabetic rats.
    Melin J; Hellberg O; Funa K; Hällgren R; Larsson E; Fellström BC
    Nephron Exp Nephrol; 2006; 103(3):e86-94. PubMed ID: 16554665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When does vesicoureteral reflux in pediatric kidney transplant patients need treatment?
    Wu HY; Concepcion W; Grimm PC
    Pediatr Transplant; 2018 Dec; 22(8):e13299. PubMed ID: 30324753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hyaluronan synthesis inhibitor delays the progression of diabetic kidney disease in a mouse experimental model.
    Selman G; Martinez L; Lightle A; Aguilar A; Woltmann D; Xiao Y; Vazquez-Padron RI; Salman LH
    Kidney360; 2021 May; 2(5):809-818. PubMed ID: 34350420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
    Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M
    J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Inflammation and Fibrosis: A Double-edged Sword.
    Black LM; Lever JM; Agarwal A
    J Histochem Cytochem; 2019 Sep; 67(9):663-681. PubMed ID: 31116067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic Acid as a New Biomarker to Differentiate Acute Kidney Injury From Chronic Kidney Disease.
    Akin D; Ozmen S; Yilmaz ME
    Iran J Kidney Dis; 2017 Nov; 11(6):409-413. PubMed ID: 29190600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal interstitial hyaluronan: functional aspects during normal and pathological conditions.
    Stridh S; Palm F; Hansell P
    Am J Physiol Regul Integr Comp Physiol; 2012 Jun; 302(11):R1235-49. PubMed ID: 22513743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of IL-10 in kidney disease.
    Wei W; Zhao Y; Zhang Y; Jin H; Shou S
    Int Immunopharmacol; 2022 Jul; 108():108917. PubMed ID: 35729842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of magnetic resonance imaging for noninvasive evaluation of diabetic nephropathy.
    Brown RS; Sun MRM; Stillman IE; Russell TL; Rosas SE; Wei JL
    Nephrol Dial Transplant; 2020 Jun; 35(6):970-978. PubMed ID: 31329940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets.
    Kim J; Seki E
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36930869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition.
    van Aanhold CCL; Koudijs A; Dijkstra KL; Wolterbeek R; Bruijn JA; van Kooten C; Baelde HJ
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathway from Acute Kidney Injury to Chronic Kidney Disease: Molecules Involved in Renal Fibrosis.
    Niculae A; Gherghina ME; Peride I; Tiglis M; Nechita AM; Checherita IA
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Plasma Hyaluronan and Hyaluronidase Be Used As Markers of the Endothelial Glycocalyx State in Patients with Kidney Disease?
    Vlahu CA; Krediet RT
    Adv Perit Dial; 2015; 31():3-6. PubMed ID: 26714379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-molecular weight hyaluronan attenuates tubulointerstitial scarring in kidney injury.
    Wang X; Balaji S; Steen EH; Blum AJ; Li H; Chan CK; Manson SR; Lu TC; Rae MM; Austin PF; Wight TN; Bollyky PL; Cheng J; Keswani SG
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32396531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
    Wang SN; Hirschberg R
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.